Serum levels of eotaxin were also used in ROC analysis to distinguish the mild severity group from all others, and the AUC for eotaxin was 0.797 (p=0.013) (Figure 4L), suggesting that eotaxin is a potential biomarker of mild COVID-19. The gene discussed is CCL11; the disease is COVID-19.